Menu
Menu
Universal Biosensors announces Euro launches

Universal Biosensors announces Euro launches

Medical diagnostics company Universal Biosensors (ASX:UBI) has announced the launch of the OneTouch Verio in Italy and France.

The OneTouch Verio is a diabetes self-monitoring product which Universal Biosensors helped develop for LifeScan.

UBI shares grew 1% in Tuesday's trading to $1.520.

Join the CIO Australia group on LinkedIn. The group is open to CIOs, IT Directors, COOs, CTOs and senior IT managers.

Join the newsletter!

Or

Sign up to gain exclusive access to email subscriptions, event invitations, competitions, giveaways, and much more.

Membership is free, and your security and privacy remain protected. View our privacy policy before signing up.

Error: Please check your email address.

Tags e-healthUniversal BiosensorsOneTouch Verioself-monitoringASX:UBI

Show Comments
Computerworld
ARN
Techworld
CMO